v3.26.1
Restated Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2023
Cash flows provided by operating activities:                              
Net income $ (284,183) $ 203,516 $ 160,812 $ 213,268 $ 82,776 $ 148,337 $ 153,901 $ 108,045 $ 108,877 $ 364,328 $ 231,113 $ 216,922 $ 80,145 $ 444,381 $ 370,823
Adjustments to reconcile net income to net cash provided by operating activities:                              
Depreciation and amortization expense     95,958     149,181     145,126 193,676 298,816 290,185 292,706 391,845 436,217
Goodwill impairment 364,248   0 0     0     0     364,248 0 0
Impairment of non-financial assets 101,027   0 0     0     0     101,027 0 0
Impairment of operating right-of-use assets and related property, plant and equipment     0     0     6,933 5,573 12,559 8,613 5,573 12,559 8,845
Reduction in carrying value of operating right-of-use assets     9,384     11,472     11,304 18,977 19,367 23,607 29,473 29,820 33,979
Loss on equity method investments             0 0 383     383     383
Acquisition-related gain                 0     (6,160)     (6,160)
Amortization of financing costs and debt discount     1,480     3,907     4,497 2,971 20,604 7,899 4,470 22,066 12,485
Stock compensation expense     12,359     13,181     14,759 27,610 28,145 31,357 72,529 41,183 47,303
Deferred tax benefit     (25,014)     (34,757)     (44,413) (46,095) (60,209) (60,355) (114,257) (85,646) (116,367)
Unrealized foreign exchange movements     18,081     (1,027)     (1,319) 34,777 13,761 (3,345) 24,661 34,018 (7,670)
Other non-cash items     8,240     4,629     17,534 15,266 12,463 18,202 20,561 26,828 21,966
Changes in operating assets and liabilities:                              
Accounts receivable     481     53,600     (93,259) 15,149 173,821 (40,675) (8,212) 326,877 (139,096)
Unbilled revenue     (66,376)     (97,327)     90,759 (138,521) (176,109) 70,760 (157,162) (279,550) 143,058
Unearned revenue     23,463     20,284     (18,970) 25,761 (22,289) (14,642) 64,542 (92,192) 59,034
Other net assets     29,372     55,596     (66,711) (105,031) (6,377) (163,370) 21,739 76,149 (143,904)
Net cash provided by operating activities     268,240     327,076     175,500 414,441 545,665 379,381 802,043 948,338 720,896
Cash flows used in investing activities:                              
Purchase of property, plant and equipment     (28,907)     (27,152)     (26,744) (61,185) (63,440) (58,880) (114,885) (106,772) (87,980)
Purchase of subsidiary undertakings (net of cash acquired)     (2,537)     (7,831)     0 (2,537) (7,831) (5,100) (2,537) (85,629) (5,100)
Movement of available for sale investments           (1)     60   1,954 60   1,954 (241)
Proceeds from investments in equity     103     0       561 1,373   2,114 2,671  
Purchase of investments in equity     (5,941)     (4,381)     (1,358) (12,330) (5,621) (4,733) (16,286) (10,131) (10,829)
Net cash used in investing activities     (37,282)     (39,365)     (28,042) (75,491) (73,565) (68,653) (131,594) (197,907) (104,150)
Cash flows used in financing activities:                              
Debt issue costs           0         (11,679)     (12,678)  
Drawdown of credit lines and loan facilities     50,000     50,000     180,000 50,000 2,192,480 230,000 50,000 2,242,480 305,000
Repayment     (57,440)     (330,000)     (350,000) (64,881) (2,537,882) (580,000) (72,321) (2,595,323) (930,000)
Proceeds from exercise of equity compensation     4,763     16,305     12,940 6,498 21,645 20,177 7,319 32,379 36,517
Share issue costs     (5)     (4)     (4) (9) (14) (9) (14) (17) (14)
Repurchase of ordinary shares     (250,000)     0       (500,000) 0   (750,000) (100,000)  
Share repurchase costs     (150)     0       (300) 0   (450) (68)  
Net cash used in financing activities     (252,832)     (263,699)     (157,064) (508,692) (335,450) (329,832) (765,466) (433,227) (588,497)
Effect of exchange rate movements on cash     9,787     (6,032)     718 21,353 (8,199) 512 25,120 201 (3,952)
Net (decrease) / increase in cash and cash equivalents     (12,087)     17,980     (8,888) (148,389) 128,451 (18,592) (69,897) 317,405 24,297
Cash and cash equivalents at beginning of period 390,396 526,698 538,785 506,553 396,082 378,102 270,176 279,880 288,768 538,785 378,102 288,768 538,785 378,102 288,768
Cash and cash equivalents at end of period 468,888 390,396 526,698 695,507 506,553 396,082 313,065 270,176 279,880 390,396 506,553 270,176 468,888 695,507 313,065
As Reported                              
Cash flows provided by operating activities:                              
Net income 2,355 182,972 154,151 197,128 146,910 187,438 163,665 115,598 116,654 337,123 334,348 232,252 339,478 531,476 395,917
Adjustments to reconcile net income to net cash provided by operating activities:                              
Depreciation and amortization expense     95,958     149,181     145,126 193,676 298,816 290,185 292,171 391,845 436,217
Goodwill impairment 165,300   0             0     165,300    
Impairment of non-financial assets 0   0             0     0    
Impairment of operating right-of-use assets and related property, plant and equipment     0     0     6,933 5,573 12,559 8,613 5,573 12,559 8,845
Reduction in carrying value of operating right-of-use assets     9,384     11,472     11,304 18,977 19,367 23,607 29,473 29,820 33,979
Loss on equity method investments             0 0 383     383     383
Acquisition-related gain                 0     (6,160)     (6,160)
Amortization of financing costs and debt discount     1,480     3,907     4,497 2,971 20,604 7,899 4,470 22,066 12,485
Stock compensation expense     12,359     13,181     14,759 27,610 28,145 31,357 72,529 41,183 47,303
Deferred tax benefit     (25,014)     (35,145)     (43,823) (46,095) (61,239) (59,177) (91,788) (86,579) (114,487)
Unrealized foreign exchange movements     18,081     (1,027)     (1,319) 34,777 13,761 (3,345) 24,661 34,018 (7,670)
Other non-cash items     8,240     4,629     17,534 15,266 12,463 18,202 20,561 26,828 21,966
Changes in operating assets and liabilities:                              
Accounts receivable     9,706     (80,431)     (93,259) 24,374 198,749 (40,675) 1,013 352,795 (139,096)
Unbilled revenue     84,155     (42,546)     (18,346) 36,040 (287,183) (27,210) 25,979 (423,533) 14,370
Unearned revenue     (122,305)     56,485     80,990 (122,306) (52,081) 65,266 (101,089) (72,930) 158,269
Other net assets     22,045     59,932     (65,933) (113,545) 7,356 (161,816) 13,712 88,790 (141,425)
Net cash provided by operating activities     268,240     327,076     175,500 414,441 545,665 379,381 802,043 948,338 720,896
Cash flows used in investing activities:                              
Purchase of property, plant and equipment     (28,907)     (27,152)     (26,744) (61,185) (63,440) (58,880) (114,885) (106,772) (87,980)
Purchase of subsidiary undertakings (net of cash acquired)     (2,537)     (7,831)     0 (2,537) (7,831) (5,100) (2,537) (85,629) (5,100)
Movement of available for sale investments           (1)     60   1,954 60   1,954 (241)
Proceeds from investments in equity     103     0       561 1,373   2,114 2,671  
Purchase of investments in equity     (5,941)     (4,381)     (1,358) (12,330) (5,621) (4,733) (16,286) (10,131) (10,829)
Net cash used in investing activities     (37,282)     (39,365)     (28,042) (75,491) (73,565) (68,653) (131,594) (197,907) (104,150)
Cash flows used in financing activities:                              
Debt issue costs           0         (11,679)     (12,678)  
Drawdown of credit lines and loan facilities     50,000     50,000     180,000 50,000 2,192,480 230,000 50,000 2,242,480 305,000
Repayment     (57,440)     (330,000)     (350,000) (64,881) (2,537,882) (580,000) (72,321) (2,595,323) (930,000)
Proceeds from exercise of equity compensation     4,763     16,305     12,940 6,498 21,645 20,177 7,319 32,379 36,517
Share issue costs     (5)     (4)     (4) (9) (14) (9) (14) (17) (14)
Repurchase of ordinary shares     (250,000)     0       (500,000) 0   (750,000) (100,000)  
Share repurchase costs     (150)     0       (300) 0   (450) (68)  
Net cash used in financing activities     (252,832)     (263,699)     (157,064) (508,692) (335,450) (329,832) (765,466) (433,227) (588,497)
Effect of exchange rate movements on cash     9,787     (6,032)     718 21,353 (8,199) 512 25,120 201 (3,952)
Net (decrease) / increase in cash and cash equivalents     (12,087)     17,980     (8,888) (148,389) 128,451 (18,592) (69,897) 317,405 24,297
Cash and cash equivalents at beginning of period 390,396 526,698 538,785 506,553 396,082 378,102 270,176 279,880 288,768 538,785 378,102 288,768 538,785 378,102 288,768
Cash and cash equivalents at end of period 468,888 390,396 526,698 695,507 506,553 396,082 313,065 270,176 279,880 390,396 506,553 270,176 468,888 695,507 313,065
Adjustments                              
Cash flows provided by operating activities:                              
Net income (286,538) 20,544 6,661 16,140 (64,134) (39,101) (9,764) (7,553) (7,777) 27,205 (103,235) (15,330) (259,333) (87,095) (25,094)
Adjustments to reconcile net income to net cash provided by operating activities:                              
Depreciation and amortization expense     0     0     0 0 0 0 535 0 0
Goodwill impairment 198,948   0             0     198,948    
Impairment of non-financial assets 101,027   0             0     101,027    
Impairment of operating right-of-use assets and related property, plant and equipment     0     0     0 0 0 0 0 0 0
Reduction in carrying value of operating right-of-use assets     0     0     0 0 0 0 0 0 0
Loss on equity method investments             0 0 0     0     0
Acquisition-related gain                 0     0     0
Amortization of financing costs and debt discount     0     0     0 0 0 0 0 0 0
Stock compensation expense     0     0     0 0 0 0 0 0 0
Deferred tax benefit     0     388     (590) 0 1,030 (1,178) (22,469) 933 (1,880)
Unrealized foreign exchange movements     0     0     0 0 0 0 0 0 0
Other non-cash items     0     0     0 0 0 0 0 0 0
Changes in operating assets and liabilities:                              
Accounts receivable     (9,225)     134,031     0 (9,225) (24,928) 0 (9,225) (25,918) 0
Unbilled revenue     (150,531)     (54,781)     109,105 (174,561) 111,074 97,970 (183,141) 143,983 128,688
Unearned revenue     145,768     (36,201)     (99,960) 148,067 29,792 (79,908) 165,631 (19,262) (99,235)
Other net assets     7,327     (4,336)     (778) 8,514 (13,733) (1,554) 8,027 (12,641) (2,479)
Net cash provided by operating activities     0     0     0 0 0 0 0 0 0
Cash flows used in investing activities:                              
Purchase of property, plant and equipment     0     0     0 0 0 0 0 0 0
Purchase of subsidiary undertakings (net of cash acquired)     0     0     0 0 0 0 0 0 0
Movement of available for sale investments           0     0   0 0   0 0
Proceeds from investments in equity     0     0       0 0   0 0  
Purchase of investments in equity     0     0     0 0 0 0 0 0 0
Net cash used in investing activities     0     0     0 0 0 0 0 0 0
Cash flows used in financing activities:                              
Debt issue costs           0         0     0  
Drawdown of credit lines and loan facilities     0     0     0 0 0 0 0 0 0
Repayment     0     0     0 0 0 0 0 0 0
Proceeds from exercise of equity compensation     0     0     0 0 0 0 0 0 0
Share issue costs     0     0     0 0 0 0 0 0 0
Repurchase of ordinary shares     0     0       0 0   0 0  
Share repurchase costs     0     0       0 0   0 0  
Net cash used in financing activities     0     0     0 0 0 0 0 0 0
Effect of exchange rate movements on cash     0     0     0 0 0 0 0 0 0
Net (decrease) / increase in cash and cash equivalents     0     0     0 0 0 0 0 0 0
Cash and cash equivalents at beginning of period 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cash and cash equivalents at end of period $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0